logo

GDTC

CytoMed Therapeutics·NASDAQ
--
--(--)
--
--(--)

GDTC fundamentals

CytoMed Therapeutics (GDTC) released its earnings on Apr 28, 2025: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.
Revenue / YoY
--
--
EPS / YoY
--
--
Report date
Apr 28, 2025

Earnings

EPS
Revenue

Revenue & Expenses

Key Indicators

CytoMed Therapeutics (GDTC) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

CytoMed Therapeutics (GDTC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

CytoMed Therapeutics (GDTC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

CytoMed Therapeutics (GDTC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does CytoMed Therapeutics (GDTC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track CytoMed Therapeutics (GDTC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield